The company that makes Atripla will make sure that the medicine is used safely, bearing in mind concerns over possible effects of tenofovir disoproxil on the kidneys.
Atriplat tootev ettevõte tagab ravimi ohutu kasutamise, pidades silmas tenofoviirdisoproksiili võimalikku toimet neerudele.